TOLREMO therapeutics Revenue

Biotechnology Research • Basel, Basel, Switzerland • 11-20 Employees

TOLREMO therapeutics revenue & valuation

Annual revenue	$1,300,000
Revenue per employee	$87,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	$37,900,000

Key Contact at TOLREMO therapeutics

Stefanie Flückiger-Mangual

Ceo And Co-Founder

Company overview

Headquarters	Hochbergerstrasse 60c, Basel, BS 4057, CH
Website	tolremo.com
NAICS	541714
SIC	873
Keywords	Biotech, Drug Discovery, Drug Development, Cancer Drug Resistance, Non-Genetic Cancer Drug Resistance
Founded	2017
Employees	11-20
Socials

TOLREMO therapeutics Email Formats

TOLREMO therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@tolremo.com), used 66.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@tolremo.com	66.7%
{first initial}.{last name}	j.doe@tolremo.com	33.3%

About TOLREMO therapeutics

TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies. Led by phenotypic insights, we discovered a pivotal mechanism that governs critical transcriptional resistance pathways. Our clinical compound TT125-802 is an orally available small molecule inhibitor designed to block these survival techniques to significantly improve the response rates and durability of established treatments. By stopping cancer drug resistance as it emerges, we aim to surmount a universal challenge for current and future targeted therapies for lasting patient benefit.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Entry

Manager

Employees by Department

TOLREMO therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore TOLREMO therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-10-20	4	$37,900,000

Funding Insights

$37,900,000

Total funding amount

$37,900,000

Most recent funding amount

Number of funding rounds

TOLREMO therapeutics Tech Stack

Discover the technologies and tools that power TOLREMO therapeutics's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

Google Tag Manager

Tag managers

Hostpoint

Hosting

Open Graph

Miscellaneous

HSTS

Security

core-js

JavaScript libraries

Google Analytics

Analytics

YouTube

Video players

Frequently asked questions

TOLREMO therapeutics is located in Basel, Basel, CH.

TOLREMO therapeutics generates an estimated annual revenue of $1,300,000. This revenue figure reflects the company's market position and business performance in its industry.

TOLREMO therapeutics has an estimated valuation of $4,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

TOLREMO therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

TOLREMO therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

TOLREMO therapeutics has raised a total of $37,900,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at TOLREMO therapeutics

Stefanie Flückiger-Mangual

Ceo And Co-Founder

4.8

40,000 users